Overview: Verzenio 150 mg (Abemaciclib)
Verzenio 150 mg, containing the active ingredient Abemaciclib, is a specialized oncology medication developed by Eli Lilly. It is classified as a selective inhibitor of cyclin-dependent kinases 4 and 6 (CDK4/6), scientifically engineered to block the signaling pathways that allow cancer cells to grow and divide.
Mechanism and Clinical Utility
Verzenio functions by inhibiting the CDK4/6 enzymes, which are key regulators of the cell cycle. By preventing these enzymes from driving the cell cycle forward, Verzenio effectively inhibits the proliferation of tumor cells. This targeted approach is essential for patients managing specific types of hormone receptor-positive, HER2-negative advanced or metastatic breast cancer.
Key Therapeutic Benefits
- Targeted CDK4/6 Inhibition: Highly specific action that targets the cell cycle machinery to effectively control tumor growth.
- Advanced Oncology Support: Designed as a targeted therapy, offering a precise approach to managing malignancies.
- Clinical Reliability: Developed by Eli Lilly, a global leader in medical research, ensuring high standards of therapeutic efficacy.
- Precise Dosing: Provided as 150 mg tablets, allowing for flexible and accurate titration according to oncologist recommendations.
Product Details and Usage
Verzenio 150 mg is provided in a 14-tablet pack, representing a 7-day supply. This presentation is designed to support the specific dosing schedules required for effective long-term oncology management.
Safety and Storage Guidelines
Administration: Must be taken strictly as prescribed by your oncologist. Adjustments to therapy or dosing must be performed only by authorized medical professionals.
Storage: Store the tablets in their original packaging in a cool, dry place. Keep out of reach of children and ensure the storage environment remains within standard temperature limits.
Healthcare Collaboration: Maintain consistent communication with your oncology care team and the specialists at El-Masry Pharmacy to ensure optimal treatment outcomes and to address any clinical concerns promptly.
Disclaimer: Verzenio is a specialized, prescription-only oncology medication. Ensure you hold a valid prescription and consult with your healthcare provider before beginning any treatment plan.
You can add a rating once you purchase the product through the My Orders page
